Navigation Links
Developing Sales Leaders: Benchmarks Reveal Tactics that Will Propel Your Business
Date:4/14/2008

CHAPEL HILL, N.C., April 14 /PRNewswire/ -- For 88 percent of companies, front-line and mid-level leaders participate in sales leadership development programs, which cover a variety of development skills but focus strongly on techniques for leading, influencing and coaching others.

Yet only half of executive-level sales leaders attend the programs, perhaps due to having received previous leadership development and training, according to a member-driven research study conducted by Best Practices, LLC's GLOBAL BENCHMARKING COUNCIL.

Download this complimentary research excerpt, "Sales Management Leadership Development Programs: Structuring for Success," at http://www3.best-in-class.com/gr151.htm to view an example of research the GBC could conduct for you on a current or future burning issue at your organization.

Benchmarking studies are one way members of the GLOBAL BENCHMARKING COUNCIL use this innovative research, benchmarking and networking service. The comprehensive suite of research services not only helps them promote top-line revenue growth, cost reduction and innovative problem-solving in the organization, but also supports their personal thought leadership and status as an information broker.

The GLOBAL BENCHMARKING COUNCIL provides five forms of insight, service and assistance, including:

-- Group research to enable informed decision-making

-- Custom research to support key priorities

-- Access to existing $35 million in research via the Best Practice

Database to enlighten day-to-day leadership

-- Access to group knowledge exchanges

-- Thought leadership support via annual conferences on critical business

issues

Want to test-drive the GLOBAL BENCHMARKING COUNCIL? - Visit http://www3.best-in-class.com/gbc to sign up for a no cost, no obligation Virtual Tour or experience it yourself at the upcoming conference, http://www3.best-in-class.com/CurrentConference. Discover the positive impact this innovative research, benchmarking and networking service can have on your career and company.

Contact Anna Buhr at 919.809.7560 or abuhr@best-in-class.com to discuss our line-up of conferences or to explore research and networking opportunities available to you through the GLOBAL BENCHMARKING COUNCIL service.

Best Practices, LLC's GLOBAL BENCHMARKING COUNCIL is an innovative research, benchmarking and networking service for business executives in pharmaceutical and life sciences, consumer and industrial products manufacturing, financial services and other industries to promote top-line revenue growth, cost reduction and innovative problem-solving.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
2. DuPont, Genencor International and Tate & Lyle Honored for Groundbreaking Work in Developing Bio-PDO(TM)
3. International Atomic Energy Agency and National Foundation for Cancer Research Launch Major Initiative to Improve Cancer Prevention and Treatments in Developing Countries
4. Free CME-certified Webcast: Making Your Case: Up-to-date Answers for Developing Trends in PCI
5. The Diabetes Series 2008: Experts Speak About Developing Diabetes Therapeutics
6. Microchip Biotechnologies, Inc. Collaborating With Stanford University on Developing a Front End Microfluidic-Based Sample Preparation System for Pyrosequencing Platforms
7. Allen Institute for Brain Science Launches Three New Landmark Atlas Projects Focusing on the Human Brain, Developing Brain and Spinal Cord
8. Genetic Engineering & Biotechnology News reports on clinical trials in developing countries
9. Iowa State researchers developing system to efficiently convert biomass to ethanol
10. Pharmaceuticals & Biotechs to Share Insights for Developing Leaders in a Fast-Paced, Competitive Industry
11. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... China Cord Blood Corporation (NYSE: CO ) ... blood collection, laboratory testing, hematopoietic stem cell processing and ... results for the third quarter and first nine months ... Third Quarter of Fiscal 2017 Highlights ... increased by 18.6% to RMB200.9 million ($28.9 million). ...
(Date:2/24/2017)... -- China Biologic Products, Inc. (NASDAQ: CBPO) ("China Biologic" or ... China, today announced its financial results for the fourth quarter ... 2016 Financial Highlights Total sales in ... terms, or increased by 13.6% in USD terms to $77.6 ... Gross profit increased by 13.3% to $46.8 ...
(Date:2/24/2017)...  OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company ... Opinion Leader event to highlight new clinical data that ... at the upcoming 2017 ASCO-SITC Immuno-Oncology Symposium and the ... held in-person and via live webcast on Tuesday, February ... at the Lotte New York Palace Hotel in ...
(Date:2/23/2017)... Financial ... data, unaudited)Three Months Ended December 31,Twelve Months Ended December ... $           300$ ... Net Product Revenue 3539(10)%9498(4)%Kuvan Net ... Revenue  756025%297303(2)%Vimizim Net Product Revenue ...
Breaking Biology Technology:
(Date:2/7/2017)... New York , February 7, 2017 ... as ID Global Solutions Corporation [OTC: IDGS], ("Ipsidy" or ... management and electronic transaction processing services, is pleased to ... of the Company. Effective January 31, 2017, ... the Board of Directors, CEO and President.  An experienced ...
(Date:2/3/2017)... SAN ANTONIO , Feb. 3, 2017  Texas Biomedical ... Dr. Larry Schlesinger as the Institute,s ... of Texas Biomed effective May 31, 2017. He is currently ... and Director of the Center for Microbial Interface Biology at ... Dr. Schlesinger as the new President and CEO of Texas ...
(Date:2/2/2017)... , Feb. 2, 2017   TapImmune, Inc. ... immuno-oncology company specializing in the development of innovative ... treatment of cancer and metastatic disease, announced today ... GMP manufacturing of a second clinical lot of ... folate receptor alpha. The manufactured vaccine product will ...
Breaking Biology News(10 mins):